產(chǎn)品名稱 BMS 204352, (±)-
產(chǎn)品貨號(hào) Axon 1308 CAS [183720-28-7] MF C16H10ClF4NO2MW 359.70 Purity: 98% Soluble in DMSO Description Potassium channel opener; racemate of more active S-(+)-enantiomer, BMS-204352 (Flindokalner, Axon 1112), and less active R-(-)-enantiomer (Axon 1309) References Certificates Categories Extra info Krishna R et al. Pharmacokinetics and dose proportionality of BMS-204352 after intraarterial administration to rats. Biopharm Drug Dispos. 2002, 23(6), 233-7. ? M. P. G. Korsgaard et al. Anxiolytic Effects of Maxipost (BMS-204352) and Retigabine via Activation of Neuronal Kv7 Channels. J. Pharmacol. Exp. Ther. 2005, 314, 282-292. Certificate of Analysis Material Safety Data Sheet Cardiovascular CNS KCa1.1 KCNMA1 Potassium channel opener; racemate of Axon 1112 Chemical name 3-(5-Chloro-2-methoxy-phenyl)-3-fluoro-6-trifluoromethyl-1,3-dihydro-indol-2-one Parent CAS No. [183720-28-7] Inquire
產(chǎn)品價(jià)格 現(xiàn)貨詢價(jià)，電話：010-67529703
產(chǎn)品規(guī)格
產(chǎn)品品牌 axonmedchem
產(chǎn)品概述
產(chǎn)品詳情

BMS 204352, (±)-

Based on 12 reference(s) in Google Scholar 9 10 12

Axon 1308

CAS [183720-28-7]

MF C16H10ClF4NO2
MW 359.70

  • Purity: 98%
  • Soluble in DMSO

BMS 204352, (±)-

Description

Potassium channel opener; racemate of more active S-(+)-enantiomer, BMS-204352 (Flindokalner, Axon 1112), and less active R-(-)-enantiomer (Axon 1309)
產(chǎn)品資料